Form 483

Patheon Puerto Rico, Inc. Form 483, 2015-09-03

FDA issued a Form 483 to Patheon Puerto Rico, Inc. on 2015-09-03 with 15 public-safe observations.

483· Form 483 issuedHuman Drugs15 observations

Patheon Puerto Rico, Inc. · Manati, United States · Issued September 3, 2015

Overview

  • 15 public-safe observations are available for this inspection.
  • 5 structured CFR citations are represented.
  • 3 investigators are tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

3 Sep 2015
21 CFR 211.110(a)

Control procedures to monitor and validate performance

Cited by Doan T Nguyen, Jose E Melendez, Cassandra L Abellard

3 Sep 2015
21 CFR 211.110(a)

Control procedures to monitor and validate performance

Cited by Doan T Nguyen, Jose E Melendez, Cassandra L Abellard

3 Sep 2015
21 CFR 211.110(a)

Control procedures to monitor and validate performance

Cited by Doan T Nguyen, Jose E Melendez, Cassandra L Abellard

3 Sep 2015
21 CFR 211.198(b)(2)

Complaint Investigation/Follow-Up Findings

Cited by Doan T Nguyen, Jose E Melendez, Cassandra L Abellard

3 Sep 2015
21 CFR 211.198(b)(2)

Complaint Investigation/Follow-Up Findings

Cited by Doan T Nguyen, Jose E Melendez, Cassandra L Abellard

Inspected site

PPPatheon Puerto Rico, Inc.Manati, United States

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.110(a)Cited across public-safe Form 483 observations3x
21 CFR 211.198(b)(2)Cited across public-safe Form 483 observations3x
21 CFR 211.22(d)Cited across public-safe Form 483 observations3x
21 CFR 211.80(a)Cited across public-safe Form 483 observations3x
21 CFR 211.80(b)Cited across public-safe Form 483 observations3x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 15 observations

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere